398 related articles for article (PubMed ID: 32345916)
1. A randomized, double-blind, placebo-controlled study of daily cannabidiol for the treatment of canine osteoarthritis pain.
Verrico CD; Wesson S; Konduri V; Hofferek CJ; Vazquez-Perez J; Blair E; Dunner K; Salimpour P; Decker WK; Halpert MM
Pain; 2020 Sep; 161(9):2191-2202. PubMed ID: 32345916
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Effect of Cannabidiol on Naturally Occurring Osteoarthritis-Associated Pain: A Pilot Study in Dogs.
Mejia S; Duerr FM; Griffenhagen G; McGrath S
J Am Anim Hosp Assoc; 2021 Mar; 57(2):81-90. PubMed ID: 33450016
[TBL] [Abstract][Full Text] [Related]
3. The effects of a brand-specific, hemp-derived cannabidiol product on physiological, biochemical, and psychometric outcomes in healthy adults: a double-blind, randomized clinical trial.
Mastrofini GF; McFadden BA; Chandler AJ; Lints BS; Cintineo HP; Rhoades ND; Vincenty CS; Stray-Gundersen SO; Lane AD; Arent SM
J Int Soc Sports Nutr; 2024 Dec; 21(1):2370430. PubMed ID: 38904150
[TBL] [Abstract][Full Text] [Related]
4. Use of cannabis in the treatment of animals: a systematic review of randomized clinical trials.
Lima TM; Santiago NR; Alves ECR; Chaves DSA; Visacri MB
Anim Health Res Rev; 2022 Jun; 23(1):25-38. PubMed ID: 35703023
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of early phase inflammation by cannabidiol prevents pain and nerve damage in rat osteoarthritis.
Philpott HT; O'Brien M; McDougall JJ
Pain; 2017 Dec; 158(12):2442-2451. PubMed ID: 28885454
[TBL] [Abstract][Full Text] [Related]
6. Cannabidiol treatment in hand osteoarthritis and psoriatic arthritis: a randomized, double-blind, placebo-controlled trial.
Vela J; Dreyer L; Petersen KK; Arendt-Nielsen L; Duch KS; Kristensen S
Pain; 2022 Jun; 163(6):1206-1214. PubMed ID: 34510141
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of cannabidiol for the treatment of canine osteoarthritis: a systematic review and meta-analysis of animal intervention studies.
Patikorn C; Nerapusee O; Soontornvipart K; Lawonyawut K; Musikpodok K; Waleethanaphan K; Anantachoti P
Front Vet Sci; 2023; 10():1248417. PubMed ID: 37781283
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammation and gingival wound healing activities of Cannabis sativa L. subsp. sativa (hemp) extract and cannabidiol: An in vitro study.
Kongkadee K; Wisuitiprot W; Ingkaninan K; Waranuch N
Arch Oral Biol; 2022 Aug; 140():105464. PubMed ID: 35623115
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics, Safety, and Clinical Efficacy of Cannabidiol Treatment in Osteoarthritic Dogs.
Gamble LJ; Boesch JM; Frye CW; Schwark WS; Mann S; Wolfe L; Brown H; Berthelsen ES; Wakshlag JJ
Front Vet Sci; 2018; 5():165. PubMed ID: 30083539
[No Abstract] [Full Text] [Related]
10. Scientific Validation of Cannabidiol for Management of Dog and Cat Diseases.
Corsato Alvarenga I; Panickar KS; Hess H; McGrath S
Annu Rev Anim Biosci; 2023 Feb; 11():227-246. PubMed ID: 36790884
[TBL] [Abstract][Full Text] [Related]
11. Cannabidiol-based natural health products for companion animals: Recent advances in the management of anxiety, pain, and inflammation.
Yu CHJ; Rupasinghe HPV
Res Vet Sci; 2021 Nov; 140():38-46. PubMed ID: 34391060
[TBL] [Abstract][Full Text] [Related]
12. The efficacy and safety of cannabidiol as adjunct treatment for drug-resistant idiopathic epilepsy in 51 dogs: A double-blinded crossover study.
Rozental AJ; Weisbeck BG; Corsato Alvarenga I; Gustafson DL; Kusick BR; Rao S; Bartner LR; McGrath S
J Vet Intern Med; 2023; 37(6):2291-2300. PubMed ID: 37889215
[TBL] [Abstract][Full Text] [Related]
13. Randomized, placebo-controlled, 28-day safety and pharmacokinetics evaluation of repeated oral cannabidiol administration in healthy dogs.
Vaughn DM; Paulionis LJ; Kulpa JE
Am J Vet Res; 2021 May; 82(5):405-416. PubMed ID: 33904801
[TBL] [Abstract][Full Text] [Related]
14. Effects of cannabidiol without delta-9-tetrahydrocannabinol on canine atopic dermatitis: A retrospective assessment of 8 cases.
Mogi C; Yoshida M; Kawano K; Fukuyama T; Arai T
Can Vet J; 2022 Apr; 63(4):423-426. PubMed ID: 35368394
[TBL] [Abstract][Full Text] [Related]
15. The effect of cannabidiol on canine neoplastic cell proliferation and mitogen-activated protein kinase activation during autophagy and apoptosis.
Henry JG; Shoemaker G; Prieto JM; Hannon MB; Wakshlag JJ
Vet Comp Oncol; 2021 Jun; 19(2):253-265. PubMed ID: 33247539
[TBL] [Abstract][Full Text] [Related]
16. Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo controlled, randomised clinical trial of efficacy and safety of cannabidiol (CBD).
Good P; Haywood A; Gogna G; Martin J; Yates P; Greer R; Hardy J
BMC Palliat Care; 2019 Dec; 18(1):110. PubMed ID: 31810437
[TBL] [Abstract][Full Text] [Related]
17. An un-commissioned randomized, placebo-controlled double-blind study to test the effect of deep sea fish oil as a pain reliever for dogs suffering from canine OA.
Hielm-Björkman A; Roine J; Elo K; Lappalainen A; Junnila J; Laitinen-Vapaavuori O
BMC Vet Res; 2012 Sep; 8():157. PubMed ID: 22950577
[TBL] [Abstract][Full Text] [Related]
18. The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis.
Malfait AM; Gallily R; Sumariwalla PF; Malik AS; Andreakos E; Mechoulam R; Feldmann M
Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9561-6. PubMed ID: 10920191
[TBL] [Abstract][Full Text] [Related]
19. A phase III multisite randomised controlled trial to compare the efficacy of cannabidiol to placebo in the treatment of cannabis use disorder: the CBD-CUD study protocol.
Bhardwaj AK; Mills L; Doyle M; Sahid A; Montebello M; Monds L; Arunogiri S; Haber P; Lorenzetti V; Lubman DI; Malouf P; Harrod ME; Dunlop A; Freeman T; Lintzeris N
BMC Psychiatry; 2024 Mar; 24(1):175. PubMed ID: 38433233
[TBL] [Abstract][Full Text] [Related]
20. Randomized blinded controlled clinical trial to assess the effect of oral cannabidiol administration in addition to conventional antiepileptic treatment on seizure frequency in dogs with intractable idiopathic epilepsy.
McGrath S; Bartner LR; Rao S; Packer RA; Gustafson DL
J Am Vet Med Assoc; 2019 Jun; 254(11):1301-1308. PubMed ID: 31067185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
